Caption Management, LLC Relmada Therapeutics, Inc. Put Options Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$18.3 - $37.02 $2.31 Million - $4.68 Million	126,500 Added 93.29%	262,100 $9.7 Million
Q2 2022 Aug 15, 2022	SELL	$16.5 - $30.34 $1.08 Million - $1.98 Million	-65,300 Reduced 32.5%	135,600 $2.58 Million
Q1 2022 May 13, 2022	BUY	$16.72 - $26.99 $3.36 Million - $5.42 Million	200,900 New	200,900 $5.42 Million
Q3 2021 Nov 12, 2021	SELL	$21.86 - $34.77 $500,594 - $796,233	-22,900 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$29.55 - $39.15 $676,695 - $896,535	22,900 New	22,900 $733,000

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $10.3M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.